DeepSPV: Estimating 3D Spleen Volume from 2D Ultrasound Images Using Deep Learning

Conceptos Básicos

This paper introduces DeepSPV, a novel deep learning pipeline that accurately estimates 3D spleen volume from single or dual 2D ultrasound images, potentially revolutionizing splenomegaly detection and management, particularly in resource-constrained settings.

Resumen

• Bibliographic Information: Yuan, Z., Stojanovski, D., Li, L., Gomez, A., Jogeesvaran, H., Puyol-Antón, E., Inusa, B., & King, A. P. (2024). DeepSPV: An Interpretable Deep Learning Pipeline for 3D Spleen Volume Estimation from 2D Ultrasound Images. arXiv preprint arXiv:2411.11190v1.
• Research Objective: This study aims to develop and evaluate a deep learning-based pipeline, DeepSPV, for accurate 3D spleen volume estimation using single or dual 2D ultrasound images. This addresses the limitations of current clinical practices that rely on spleen length measurements from 2D ultrasound, which serve as a surrogate marker for the gold standard spleen volume.
• Methodology: DeepSPV consists of two main components: a U-Net for automatic spleen segmentation from 2D ultrasound images and a variational autoencoder (VAE) for volume estimation from the segmentations. Three distinct volume estimation methods using the VAE latent space were investigated: nearest neighbor searching (NN), post linear regression (PLR), and end-to-end regression VAE (RVAE). The pipeline's performance was evaluated using a dataset of synthetic ultrasound images generated by a novel ultrasound semantic diffusion model (USDM) trained on paired CT and ultrasound data. This approach was chosen due to the lack of paired 2D ultrasound images and corresponding ground truth volumes.
• Key Findings: DeepSPV, particularly the RVAE method, demonstrated superior accuracy in spleen volume estimation compared to conventional linear regression methods based on manual 2D measurements. The pipeline achieved a mean relative volume accuracy (MRVA) of 86.62% and 92.5% for single-view and dual-view settings, respectively, surpassing human expert performance. Additionally, the RVAE-CI method provided 95% confidence intervals for volume estimates, enhancing clinical utility.
• Main Conclusions: DeepSPV offers a promising solution for accurate and automated spleen volume estimation from readily available 2D ultrasound images. This approach has the potential to improve splenomegaly detection, disease monitoring, and treatment planning, especially in areas with limited access to 3D imaging modalities like CT and MRI.
• Significance: This research significantly advances the field of medical image analysis by introducing a novel deep learning pipeline for accurate 3D volume estimation from 2D ultrasound. This has significant implications for clinical practice, particularly in resource-limited settings where 2D ultrasound is the primary imaging modality.
• Limitations and Future Research: The study acknowledges the reliance on synthetic ultrasound images for evaluation due to the lack of paired 2D ultrasound and ground truth volume data. Future research should focus on validating DeepSPV on a larger and more diverse dataset of real-world 2D ultrasound images with corresponding 3D ground truth volumes. Additionally, exploring the integration of DeepSPV into clinical workflows and evaluating its impact on patient outcomes is crucial.

Estadísticas

The study used a dataset of 149 manual segmentations of CT volumes for training and evaluating the volume estimation methods.
60 spleen segmentations were obtained from the Medical Segmentation Decathlon (MSD) challenge.
89 spleen segmentations were obtained from Gibson et al. (2018), combining data from the Cancer Imaging Archive Pancreas-CT dataset and the ‘Beyond the Cranial Vault’ (BTCV) segmentation challenge.
A total of 363 2D ultrasound images from pediatric patients with SCD were used, with manual segmentations of the spleen and US cone.
The best performing DeepSPV model achieved 86.62% mean relative volume accuracy (MRVA) in the single-view setting and 92.5% MRVA in the dual-view setting.

Citas

"Splenomegaly, the enlargement of the spleen, is an important clinical indicator for various associated medical conditions, such as sickle cell disease (SCD)."
"Accurate spleen volume measurement typically requires 3D imaging modalities, such as computed tomography or magnetic resonance imaging, but these are not widely available, especially in the Global South which has a high prevalence of SCD."
"Our proposed DeepSPV is the first work to use deep learning to estimate 3D spleen volume from 2D ultrasound images and can be seamlessly integrated into the current clinical workflow for spleen assessment."

Ideas clave extraídas de

DeepSPV: An Interpretable Deep Learning Pipeline for 3D Spleen Volume Estimation from 2D Ultrasound Images

by Zhen... a las arxiv.org 11-19-2024

https://arxiv.org/pdf/2411.11190.pdf

Consultas más profundas

How might the performance of DeepSPV be affected by variations in ultrasound image quality, such as those caused by different ultrasound machines or operator experience?

DeepSPV's performance can be significantly impacted by variations in ultrasound image quality, which are often introduced by factors like different ultrasound machines or operator experience. Here's a breakdown of how these factors influence the model and potential mitigation strategies:

Ultrasound Machine Variability: Different ultrasound machines possess varying frequencies, resolutions, and image processing algorithms. These discrepancies can lead to:

Changes in Spleen Appearance: The spleen might appear with different echogenicity, texture, and boundary clarity across images from different machines.
Impact on Segmentation: DeepSPV's segmentation network, trained on specific image characteristics, might struggle to generalize to these variations, leading to inaccurate spleen boundaries.
Volume Estimation Errors: Inaccurate segmentations directly translate to errors in volume estimation, compromising the reliability of DeepSPV.

Operator Dependence: Operator experience plays a crucial role in ultrasound image acquisition. Factors like probe positioning, pressure, and patient positioning can cause:

Inconsistent Spleen Visualization: Suboptimal probe positioning or excessive pressure can obscure parts of the spleen or introduce artifacts, affecting the completeness of the segmentation.
Image Plane Variations: Slight deviations from the standard coronal or transverse planes can alter the perceived spleen dimensions, impacting volume calculations.
Addressing these challenges is crucial for DeepSPV's clinical translation:

Diverse Training Data: Incorporating images from a wide range of ultrasound machines and operators into the training dataset can improve the model's robustness to these variations.
Domain Adaptation Techniques: Techniques like domain adversarial training can be employed to minimize the discrepancy between data distributions from different sources.
Image Quality Enhancement: Pre-processing steps like speckle reduction and contrast enhancement can help standardize image quality before feeding it to DeepSPV.
Operator Training and Standardization: Standardized protocols for spleen ultrasound acquisition and operator training programs can minimize inter-operator variability.

Could the reliance on synthetic data for training and evaluation limit the generalizability of DeepSPV to real-world clinical settings, and how can this limitation be addressed in future studies?

While the use of synthetic data offers a practical solution to the challenge of obtaining paired 2D ultrasound images and 3D ground truth volumes, it's crucial to acknowledge the potential limitations this reliance might have on DeepSPV's generalizability to real-world clinical settings:

Domain Gap: Synthetic data, despite being generated to mimic real ultrasound images, might not fully capture the complexities and subtle variations present in real clinical images. This discrepancy, known as the "domain gap," can lead to reduced performance when the model encounters real-world data.
Overfitting to Synthetic Features: DeepSPV might learn features specific to the synthetic data generation process, which might not be representative of real spleen characteristics. This overfitting can hinder the model's ability to generalize to unseen real-world cases.
Addressing the limitations of synthetic data reliance is essential:

Real-World Data Validation: Rigorously validating DeepSPV's performance on a large and diverse dataset of real-world ultrasound images with corresponding 3D ground truth volumes (obtained through CT or MRI) is paramount.
Fine-tuning on Real Data: Fine-tuning the pre-trained DeepSPV model on a smaller set of labeled real-world data can help bridge the domain gap and improve its adaptation to real clinical settings.
Hybrid Training Approaches: Combining synthetic and real data during training can leverage the advantages of both. Synthetic data can provide a large-scale foundation, while real data can fine-tune the model for real-world variations.
Domain Adaptation Techniques: As mentioned earlier, techniques like domain adversarial training can be applied to minimize the discrepancy between the synthetic and real data distributions.

Beyond splenomegaly detection, what other potential applications could this technology have in diagnosing and monitoring other medical conditions involving organ volume changes?

DeepSPV's ability to estimate organ volume from 2D ultrasound images holds significant potential beyond splenomegaly detection. This technology can be extended to diagnose and monitor various medical conditions characterized by organ volume changes:

Liver Disease: Monitoring liver volume changes is crucial in conditions like cirrhosis and fatty liver disease. DeepSPV can provide a non-invasive and accessible method for tracking disease progression and treatment response.
Kidney Disease: Accurate kidney volume measurement is essential in chronic kidney disease management. DeepSPV can aid in assessing disease severity and guiding treatment decisions.
Cardiac Conditions: Monitoring heart chamber volumes is vital in conditions like heart failure. DeepSPV can potentially be adapted to estimate cardiac chamber volumes from echocardiography images, providing valuable insights into cardiac function.
Tumor Monitoring: Tracking tumor volume changes is crucial for assessing treatment response in oncology. DeepSPV can offer a non-invasive method for monitoring tumor growth or regression over time.
Fetal Growth Monitoring: Estimating fetal organ volumes, such as head circumference and abdominal circumference, is essential during pregnancy. DeepSPV can potentially be applied to fetal ultrasound images to assess fetal growth and development.
Adapting DeepSPV for these applications would require:

Organ-Specific Training: Training the model on datasets specific to each organ, encompassing a range of normal and pathological variations, is essential.
Anatomical Considerations: Adjustments to the model's architecture or training process might be needed to account for the unique anatomical characteristics of each organ.
Clinical Validation: Thorough clinical validation is crucial to establish the accuracy and reliability of DeepSPV for each specific application.